当前位置:首页 - 行情中心 - 正海生物(300653) - 财务分析

正海生物

(300653)

  

流通市值:37.04亿  总市值:37.04亿
流通股本:1.80亿   总股本:1.80亿

正海生物(300653)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.27亿元,每股收益0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益91541.09万元,未分配利润51671.07万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产101170.08万元,负债9629.00万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入97,415,845.21363,225,351.49291,348,252.99198,024,061.1
营业总成本69,470,342.54235,693,995.77167,592,844.19111,554,445.87
营业利润31,214,045.93152,507,129.31143,286,089.8598,573,535.73
利润总额31,238,886.07152,377,776.26143,368,675.1198,570,751.65
净利润26,626,723.19134,639,109125,055,698.0886,032,106.41
其他综合收益----
综合收益总额26,626,723.19134,639,109125,055,698.0886,032,106.41
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计749,093,740.23712,700,493.26708,663,060.52686,057,915.03
非流动资产合计262,607,080.24267,413,128.73268,738,008.23273,932,113.88
资产总计1,011,700,820.47980,113,621.99977,401,068.75959,990,028.91
流动负债合计86,064,031.680,789,269.771,359,025.7369,842,897.82
非流动负债合计10,225,933.9410,540,220.5511,191,600.8215,035,608.45
负债合计96,289,965.5491,329,490.2582,550,626.5584,878,506.27
归属于母公司股东权益合计915,410,854.93888,784,131.74894,850,442.2875,111,522.64
股东权益合计915,410,854.93888,784,131.74894,850,442.2875,111,522.64
负债和股东权益合计1,011,700,820.47980,113,621.99977,401,068.75959,990,028.91
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计113,607,783.91405,312,446.2306,772,298.59204,744,045.66
经营活动现金流出小计74,659,972.78253,928,490.48185,298,793.83122,473,240.76
经营活动产生的现金流量净额38,947,811.13151,383,955.72121,473,504.7682,270,804.9
投资活动现金流入小计293,907,815.971,382,370,699.471,108,343,284.75892,760,490.23
投资活动现金流出小计382,133,869.211,286,708,179.42969,065,676.33783,431,078.5
投资活动产生的现金流量净额-88,226,053.2495,662,520.05139,277,608.42109,329,411.73
筹资活动现金流入小计----
筹资活动现金流出小计-193,933,815.68178,280,236.25158,994,583.75
筹资活动产生的现金流量净额--193,933,815.68-178,280,236.25-158,994,583.75
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-49,278,242.1153,112,660.0982,470,876.9332,605,632.88
期末现金及现金等价物余额62,401,185.88111,679,427.99141,037,644.8391,172,400.78
最新报告期:2025-04-20
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西部证券陆伏崴0.850.981.152025-04-20
中金公司张琎,刘雅馨,朱言音0.840.96--2025-04-19
华泰证券代雯,孔垂岩,王殷杰0.840.941.042025-04-15
TOP↑